Drug Target Review2024-05-02T12:00:52
Researchers have revealed that genetically enhanced expression of GSDMB causes a disturbed interferon-response.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2026-08-11T07:02:00Z
Contributor Professor Joseph C. Wu, Drug Target Review
2026-08-11T07:02:00
Contributor Professor Joseph C. Wu, Drug Target Review
2025-11-19T16:00:00
Sponsored by Eurofins DiscoverX
2025-05-28T14:00:00
Sponsored by Eurofins DiscoverX
2023-11-24T12:06:45
Sponsored by Quantum-Si
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2026-08-03T06:00:00
Author Dr Xiaoxiao Wang, Yan Zhang and Junli Zhao
Site powered by Webvision Cloud